The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The predictive value of clinical variables in patients affected with non-small-cell lung cancer (NSCLC) treated with pemetrexed (PEM) plus platinum-based regimen: A retrospective analysis.
Maria Agnese Fabbri
No relevant relationships to disclose
Luca Moscetti
No relevant relationships to disclose
Fabrizio Nelli
No relevant relationships to disclose
Teresa Gamucci
No relevant relationships to disclose
Giovanni Mansueto
No relevant relationships to disclose
Filomena Narducci
No relevant relationships to disclose
Silvia Quadrini
No relevant relationships to disclose
Isabella Sperduti
No relevant relationships to disclose
Antonio Passaro
No relevant relationships to disclose
Giuseppe Campenni
No relevant relationships to disclose
Enrico Cortesi
No relevant relationships to disclose
Olga Martelli
No relevant relationships to disclose
Sara Bianchetti
No relevant relationships to disclose
Francesco Angelini
No relevant relationships to disclose
Arianna Pellegrino
No relevant relationships to disclose
Ida Pavese
No relevant relationships to disclose
Carlo Signorelli
No relevant relationships to disclose
Enzo Maria Ruggeri
No relevant relationships to disclose